Modivcare Appoints Nathan Vaughn as Chief Diversity Officer and Vice President, Talent Acquisition
DENVER–(BUSINESS WIRE)–Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that…
DENVER–(BUSINESS WIRE)–Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that…
HOUSTON–(BUSINESS WIRE)–Senior executives and founders of eight companies selected as 2022 Energy Innovation Pioneers will…
Hyperlight launching first pilot plant in California to demonstrate its new application of concentrated solar…
Modern Charcoal Kettle Design and Performance Meets 1950s-Inspired Features to Honor the Innovative Roots of…
API and Service Connectivity Leader Further Expands Executive Leadership Team to Accelerate Growth and Scale…
Rapid European Customer Growth in Enterprise, Genomic Research, Online Gaming, and Media and Entertainment Drive…
Annual report reveals another record-breaking year of API calls on the Twilio Segment platform, signals…
SANTA CLARA, Calif.–(BUSINESS WIRE)–SoundHound Inc., a global leader in voice artificial intelligence (AI), currently in…
Seasoned telecom experts join Bluewave’s growing roster of industry leaders PARSIPPANY, N.J.–(BUSINESS WIRE)–#CTO—Bluewave Technology Group…
Kumu Demonstrates “Camelot” RFIC capable of providing the self-interference cancellation required for sub-band full duplex…
It is predicted that unlicensed access to the 6 GHz band will add US$ 187.63…
Munich, 24 February 2022 – Codasip, the leader in processor design automation, today announced the…
Ativa suite provides 360° intelligence and operations across digital experiences, apps, services, networks and infrastructure…
Additional analyses ongoing from Phase 2/3 Illuminate trial of sepofarsen in LCA10 with updates on…
WATERTOWN, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
– Data from Cohort A of the Ongoing Phase 1/2 Trial of CFT7455, a Novel…
– Received FDA Approval of PYRUKYND® (mitapivat) for the Treatment of Hemolytic Anemia in Adults…
Fast Track designation granted by the U.S. Food and Drug Administration (FDA) to Wee1 Inhibitor,…
NEW HAVEN, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
EMERYVILLE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…